Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 903-919-3 | CAS number: -
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Three GLP-compliant in vitro tests with reaction mass of 2,2'-oxybisbutane (DSBE), DIPE, SBA and 2-methylpropan-2-ol (TBA), a bacterial reverse mutation assay (Ames test), a mammalian chromosome aberration test, and a mammalian cell gene mutation test, were conducted.
The reported data of the bacterial reverse mutation assay show that under the experimental conditions applied, the substance did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
In the mammalian chromosome aberration test, the substance did not induce structural chromosome aberrations in this test in Chinese Hamster lung cells, both with and without metabolic activation.
In the mammalian cell gene mutation test, the substance did not induce gene mutations in presence and absence of metabolic activation in the cultured mammalian cells (L5178Y TK+/- 3.7.2 C mouse lymphoma cell line) used.
Hence, in all three different tests, the gene toxicity of reaction mass of 2,2'-oxybisbutane (DSBE), DIPE, SBA and 2-methylpropan-2-ol (TBA) was evaluated "negative". The substance can be regarded as not mutagenic.
Short description of key information:
The genetic toxicity of reaction mass of 2,2'-oxybisbutane (DSBE), DIPE, SBA and 2-methylpropan-2-ol (TBA) has been assessed in 3 GLP compliant in vitro studies, including a bacterial reverse mutation assay, a mammalian chromosome aberration test and a mammalian cell gene mutation test. Negative results were reported in all studies in the presence and/or absence of metabolic activation.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The criteria for classification as mutagenic were not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
